000 01266 a2200301 4500
005 20250513033959.0
264 0 _c19950811
008 199508s 0 0 eng d
022 _a0272-6386
024 7 _a10.1016/0272-6386(95)90170-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLevine, D M
245 0 0 _aLipoprotein(a) levels in patients receiving renal replacement therapy: methodologic issues and clinical implications.
_h[electronic resource]
260 _bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_cJul 1995
300 _a162-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aEnzyme-Linked Immunosorbent Assay
_xmethods
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xblood
650 0 4 _aKidney Transplantation
650 0 4 _aLipoprotein(a)
_xblood
650 0 4 _aPeritoneal Dialysis, Continuous Ambulatory
650 0 4 _aRenal Dialysis
650 0 4 _aRenal Replacement Therapy
700 1 _aGordon, B R
773 0 _tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_gvol. 26
_gno. 1
_gp. 162-9
856 4 0 _uhttps://doi.org/10.1016/0272-6386(95)90170-1
_zAvailable from publisher's website
999 _c7610685
_d7610685